M&A Deal Summary |
|
---|---|
Date | 2023-11-02 |
Target | Focus Staff Services |
Sector | Staffing |
Buyer(s) | Havencrest Capital Management |
Deal Type | Buyout (LBO, MBO, MBI) |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Private Equity Firm |
---|---|
Founded | 2017 |
Size | Small |
Type | Sector Focused |
Havencrest Capital Management is a Dallas-based, private equity fund manager specializing in the healthcare industry. Founded by long-time healthcare investor Christopher W. Kersey, M.D., M.B.A., Havencrest comprises a blue-chip team of investment partners, operating partners and senior advisors including some of the nation’s leading entrepreneurs, corporate executives and public policy experts.
DEAL STATS | # |
---|---|
Overall | 9 of 9 |
Sector (Staffing) | 1 of 1 |
Type (Buyout (LBO, MBO, MBI)) | 5 of 5 |
State (Texas) | 5 of 5 |
Country (United States) | 9 of 9 |
Year (2023) | 4 of 4 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2023-09-07 |
Tekton
Austin, Texas, United States Tekton is a clinical trial site network with 23 sites across Texas, Colorado, Georgia, Kansas, and Oklahoma. It conducts clinical trials across several therapeutic areas, including vaccines and infectious disease, neurology, endocrinology, immunology, and dermatology, among others. Tekton was formed in 2006 and is based in Austin, Texas. |
Buy | - |